Epigenetic therapies: targeting the CoREST complex to treat melanoma
In this interview, Jay Kalin, Instructor at Harvard Medical School, summarizes recent research into the development of epigenetic therapies to target melanoma cells.
Please sign in or register for FREE
Sign in to RxNet
Register to RxNet
RxNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.